SecFilingDex

aTYR PHARMA INC

3 SEC EDGAR filings indexed (CIK 0001339970) across 2 form types.

Filing profile

aTYR PHARMA INC (ATYR) has 3 SEC filings indexed on SecFilingDex, across 2 form types, from October 7, 2026 to November 6, 2026. The filer is classified under Biological Products (SIC 2836).

Its most frequent disclosure is the SC 13G/A (5%+ passive stake) with 2 filings — Short-form disclosure of beneficial ownership above 5% by passive investors with no control intent. 3 of these filings were disclosed in the twelve months to November 6, 2026. 2 of the 3 are amendments (a corrected or updated version of an earlier filing).

Disclosure mix

  • 2SC 13G/A5%+ passive stake · event-driven
  • 1424B5Prospectus supplement · event-driven

Profile derived from 3 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.

All filings

Authoritative source

https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1339970&type=&dateb=&owner=include&count=40 ↗

SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.

Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.